Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- Resource Type
- Article
- Authors
- Antonia, Scott J; López-Martin, José A; Bendell, Johanna; Ott, Patrick A; Taylor, Matthew; Eder, Joseph Paul; Jäger, Dirk; Pietanza, M Catherine; Le, Dung T; de Braud, Filippo; Morse, Michael A; Ascierto, Paolo A; Horn, Leora; Amin, Asim; Pillai, Rathi N; Evans, Jeffry; Chau, Ian; Bono, Petri; Atmaca, Akin; Sharma, Padmanee; Harbison, Christopher T; Lin, Chen-Sheng; Christensen, Olaf; Calvo, Emiliano
- Source
- In The Lancet Oncology July 2016 17(7):883-895
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045